Cargando…
Prevalence of Brucella endocarditis: A systematic review and meta‐analysis
BACKGROUND: Endocarditis caused by Brucella infection is one of this infection's complications, including a high mortality rate. However, studies on the prevalence of this complication have been limited to some case reports. This study investigated the prevalence of Brucella endocarditis global...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213485/ https://www.ncbi.nlm.nih.gov/pubmed/37251523 http://dx.doi.org/10.1002/hsr2.1301 |
_version_ | 1785047631447195648 |
---|---|
author | Narimisa, Negar Razavi, Shabnam Khoshbayan, Amin Masjedian Jazi, Faramarz |
author_facet | Narimisa, Negar Razavi, Shabnam Khoshbayan, Amin Masjedian Jazi, Faramarz |
author_sort | Narimisa, Negar |
collection | PubMed |
description | BACKGROUND: Endocarditis caused by Brucella infection is one of this infection's complications, including a high mortality rate. However, studies on the prevalence of this complication have been limited to some case reports. This study investigated the prevalence of Brucella endocarditis globally using a systematic review and meta‐analysis. METHODS: PubMed, Scopus, and Web of Science databases were searched using appropriate keywords until September 2022. All studies reporting the prevalence of endocarditis in patients with brucellosis were included in this current study. To investigate the pooled prevalence of Brucella endocarditis, random model was used in comprehensive meta‐analysis software. RESULTS: A total of 25 studies met the inclusion criteria and were included in the systematic review and meta‐analysis. The prevalence of Brucella endocarditis was 1.3%, and the death rate was 26.5%. The results did not show a significant difference in the prevalence of this complication in different regions. CONCLUSION: According to this study's results, the prevalence of Brucella endocarditis is low, but it includes a large percentage of the deaths of affected patients. To complete our understanding of this complication and its management, more research should be done to investigate the effect of other factors, such as age and gender. |
format | Online Article Text |
id | pubmed-10213485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102134852023-05-27 Prevalence of Brucella endocarditis: A systematic review and meta‐analysis Narimisa, Negar Razavi, Shabnam Khoshbayan, Amin Masjedian Jazi, Faramarz Health Sci Rep Narrative Review BACKGROUND: Endocarditis caused by Brucella infection is one of this infection's complications, including a high mortality rate. However, studies on the prevalence of this complication have been limited to some case reports. This study investigated the prevalence of Brucella endocarditis globally using a systematic review and meta‐analysis. METHODS: PubMed, Scopus, and Web of Science databases were searched using appropriate keywords until September 2022. All studies reporting the prevalence of endocarditis in patients with brucellosis were included in this current study. To investigate the pooled prevalence of Brucella endocarditis, random model was used in comprehensive meta‐analysis software. RESULTS: A total of 25 studies met the inclusion criteria and were included in the systematic review and meta‐analysis. The prevalence of Brucella endocarditis was 1.3%, and the death rate was 26.5%. The results did not show a significant difference in the prevalence of this complication in different regions. CONCLUSION: According to this study's results, the prevalence of Brucella endocarditis is low, but it includes a large percentage of the deaths of affected patients. To complete our understanding of this complication and its management, more research should be done to investigate the effect of other factors, such as age and gender. John Wiley and Sons Inc. 2023-05-25 /pmc/articles/PMC10213485/ /pubmed/37251523 http://dx.doi.org/10.1002/hsr2.1301 Text en © 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Narrative Review Narimisa, Negar Razavi, Shabnam Khoshbayan, Amin Masjedian Jazi, Faramarz Prevalence of Brucella endocarditis: A systematic review and meta‐analysis |
title | Prevalence of Brucella endocarditis: A systematic review and meta‐analysis |
title_full | Prevalence of Brucella endocarditis: A systematic review and meta‐analysis |
title_fullStr | Prevalence of Brucella endocarditis: A systematic review and meta‐analysis |
title_full_unstemmed | Prevalence of Brucella endocarditis: A systematic review and meta‐analysis |
title_short | Prevalence of Brucella endocarditis: A systematic review and meta‐analysis |
title_sort | prevalence of brucella endocarditis: a systematic review and meta‐analysis |
topic | Narrative Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213485/ https://www.ncbi.nlm.nih.gov/pubmed/37251523 http://dx.doi.org/10.1002/hsr2.1301 |
work_keys_str_mv | AT narimisanegar prevalenceofbrucellaendocarditisasystematicreviewandmetaanalysis AT razavishabnam prevalenceofbrucellaendocarditisasystematicreviewandmetaanalysis AT khoshbayanamin prevalenceofbrucellaendocarditisasystematicreviewandmetaanalysis AT masjedianjazifaramarz prevalenceofbrucellaendocarditisasystematicreviewandmetaanalysis |